Data security and confidentiality.
How we protect what you share with us, and what we are putting in place next.
Pharma companies, biotechs, deal teams and funds share sensitive information with us. This page explains how we protect it, and what we are putting in place next.
What we need from you
Most reads need only public data and a molecule’s known targets. We ask for proprietary data only when it improves a read you commission, and only the minimum needed. We never ask for patient-identifiable data, and public reads use public inputs only.
Confidentiality
- Commissioned reads are confidential to the client. We do not publish them, sell them or place them on the Ledger without the client’s written consent.
- We sign a mutual NDA before any proprietary data is shared.
- A molecule under a commissioned read is not chosen as a public read while that work is open.
- Access to client material is limited to the people working on the read.
How we protect data
- Encryption in transit (TLS) and at rest.
- Role-based access with multi-factor authentication, and access logs.
- Client data is kept separate by project and is never used to train any model. Our platform has no training step.
- Data is deleted or returned at the end of an engagement, as the contract sets out.
- Our team is bound by confidentiality obligations.
Data room
We are setting up a secure virtual data room for engagements. When it is live, clients will exchange files with us there instead of by email, with per-document permissions, watermarking, view-only access, an audit trail of who opened what, and expiry dates on access. Until then, we agree the transfer method with each client before any file is shared.
Compliance
We hold no positions in securities and take no fees tied to the outcome of any deal. Public reads use public information only; we do not seek, use or accept material non-public information. Our compliance pack is available on request for clients’ compliance teams.
Report a concern
If you believe you have found a security issue, email security@infinitusbio.ai. We will acknowledge it promptly.